PMID- 24564769
OWN - NLM
STAT- MEDLINE
DCOM- 20141105
LR  - 20171116
IS  - 1744-8395 (Electronic)
IS  - 1476-0584 (Linking)
VI  - 13
IP  - 4
DP  - 2014 Apr
TI  - CD11b+ DCs rediscovered: implications for vaccination.
PG  - 445-7
LID - 10.1586/14760584.2014.893196 [doi]
AB  - Dendritic cells (DCs) are potent antigen sensing and presenting cells, able to 
      both initiate and orchestrate complex immune responses. DCs are optimally 
      equipped to recognize pathogens, as well as self-antigens and vaccine components, 
      and instruct the type, magnitude and specificity of the ensuing immunity. 
      However, the DC population is remarkably heterogeneous and consists of multiple 
      subsets with different ontogeny, differentiation and functional specializations. 
      Therefore, a deeper understanding of DC subset biology is fundamental for the 
      development and implementation of innovative vaccination strategies.
FAU - Ginhoux, Florent
AU  - Ginhoux F
AD  - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research 
      (A*STAR), Biopolis, 138648, Singapore.
FAU - Schlitzer, Andreas
AU  - Schlitzer A
LA  - eng
PT  - Editorial
PT  - Research Support, Non-U.S. Gov't
DEP - 20140225
PL  - England
TA  - Expert Rev Vaccines
JT  - Expert review of vaccines
JID - 101155475
RN  - 0 (CD11b Antigen)
RN  - 0 (ITGAM protein, human)
RN  - 0 (Vaccines)
SB  - IM
MH  - CD11b Antigen/*analysis
MH  - Dendritic Cells/*chemistry/*immunology
MH  - Humans
MH  - Vaccination
MH  - Vaccines/*immunology
EDAT- 2014/02/26 06:00
MHDA- 2014/11/06 06:00
CRDT- 2014/02/26 06:00
PHST- 2014/02/26 06:00 [entrez]
PHST- 2014/02/26 06:00 [pubmed]
PHST- 2014/11/06 06:00 [medline]
AID - 10.1586/14760584.2014.893196 [doi]
PST - ppublish
SO  - Expert Rev Vaccines. 2014 Apr;13(4):445-7. doi: 10.1586/14760584.2014.893196. 
      Epub 2014 Feb 25.